Deferred Income Tax Expense (Benefit) of Merck & Co., Inc. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Merck & Co., Inc. annual and quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • Merck & Co., Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $186,000,000, a 265% decline year-over-year.
  • Merck & Co., Inc. annual Deferred Income Tax Expense (Benefit) for 2025 was $1,671,000,000, a 34% decline from 2024.
  • Merck & Co., Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was $1,249,000,000, a 34% increase from 2023.
  • Merck & Co., Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $1,899,000,000, a 21% decline from 2022.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)

Merck & Co., Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,671,000,000 -$422,000,000 -34% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $1,249,000,000 +$650,000,000 +34% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $1,899,000,000 -$331,000,000 -21% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $1,568,000,000 -$1,755,000,000 -939% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $187,000,000 +$753,000,000 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $566,000,000 -$6,000,000 -1.1% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $560,000,000 -$51,000,000 -10% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $509,000,000 +$2,112,000,000 +81% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $2,621,000,000 -$1,100,000,000 -72% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $1,521,000,000 -$757,000,000 -99% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $764,000,000 +$1,836,000,000 +71% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $2,600,000,000 -$2,270,000,000 -688% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $330,000,000 -$999,000,000 -149% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $669,000,000 +$2,206,000,000 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $1,537,000,000 -$445,000,000 -41% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
2010 $1,092,000,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY

Merck & Co., Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $186,000,000 -$135,000,000 -265% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q1 2024 $51,000,000 +$226,000,000 +82% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q1 2023 $277,000,000 +$61,000,000 +18% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q1 2022 $338,000,000 -$356,000,000 -1978% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $18,000,000 -$64,000,000 -78% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $82,000,000 -$112,000,000 -58% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $194,000,000 +$224,000,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $30,000,000 +$24,000,000 +44% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $54,000,000 +$16,000,000 +23% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $70,000,000 +$109,000,000 +61% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $179,000,000 +$125,000,000 +41% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $304,000,000 -$233,000,000 -328% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $71,000,000 -$30,000,000 -73% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $41,000,000 +$173,000,000 +81% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $214,000,000 -$366,000,000 -241% 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
Q1 2010 $152,000,000 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.